Brief: Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt As Chief Medical Officer
18/02/2026 12:24
Feb 18 (Reuters) - Aquestive Therapeutics Inc AQST.O: AQUESTIVE THERAPEUTICS APPOINTS INTERNATIONALLY RECOGNIZED ALLERGIST DR. MATTHEW GREENHAWT AS CHIEF MEDICAL OFFICER Source text: ID:nGNX7yWT5J Further company coverage: AQST.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Announces FDA Acceptance Of Anaphylm™ NDA Resubmission And PDUFA Goal Date Of March 16, 2027
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Aquestive rises on US licensing deal for seizure drug with Eton Pharma